Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Xiapex approved in E.U. for Peyronie's disease

Feb. 2, 2015

CF-602 shows promise for sexual dysfunction in preclinical studies

Jan. 28, 2015

FDA awards orphan drug status to Sparsentan for focal segmental glomerulosclerosis

Jan. 13, 2015

Keryx Biopharmaceuticals launches Auryxia in the U.S.

Dec. 24, 2014

Xiapex receives positive opinion by CHMP for Peyronie's disease

Dec. 23, 2014

Taiho Pharmaceutical patents novel compounds for urinary incontinence

Dec. 16, 2014

Phase II data for sotatercept as treatment of anemia in hemodialysis subjects

Dec. 12, 2014

Researchers present phase III clinical data for ZS-9 as treatment of hyperkalemia

Dec. 2, 2014

Kissei Pharmaceutical discloses new TRPM8 antagonists

Nov. 24, 2014

Studies compare time to ESRD in aHUS patients treated with supportive care or eculizumab

Nov. 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...